We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Directa Plus Plc | LSE:DCTA | London | Ordinary Share | GB00BSM98843 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 19.20 | 18.40 | 20.00 | 19.20 | 19.20 | 19.20 | 16,749 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Carbon And Graphite Products | 11.28M | -4.82M | -0.0730 | -2.63 | 12.68M |
TIDMDCTA
RNS Number : 7658Q
Directa Plus PLC
02 December 2016
2 December 2016
Directa Plus plc
("Directa Plus" or the "Company")
Update on potential customer impairment
Further to the statement on 18 October 2016, Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, announces that it has formally resolved matters with the customer whose regional governmental grant was rescinded and was therefore unable to complete the outstanding payments due to the Company.
Following the negotiations, below are the key terms of the agreement between the two parties:
-- The customer intends to keep one Mobile Decontamination Unit ("MDU") as they still recognise the market opportunity for the Company's Grafysorber(R) product.
-- Directa Plus will receive a further payment of EUR80,000 for the MDU being kept by the customer. The Company will take possession of the two remaining MDUs, which will then be available to be re-sold.
The net negative impairment impact on the profit and loss account for the current financial year will be approximately EUR700,000. This impairment to the accounts will be treated as a non-cash item and has no ongoing impact on Directa Plus' core business of the sale of graphene materials.
Giulio Cesareo, Chief Executive Officer of Directa Plus, said: "We are pleased to have resolved this matter. The customer remains positive about the opportunities for our Grafysorber(R) product and the return of two MDUs means the Company is in a position to immediately satisfy potential interest in the MDUs from other parties. There continues to be strong interest in this product from the Middle East, Europe and US, and we continue to view the environmental sector and our solution as a strong growth opportunity for the Company."
This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.
Enquiries
Directa Plus plc --------------------------------------- ---------------- Giulio Cesareo, CEO Marco Ferrari, CFO +39 02 36714458 --------------------------------------- ---------------- Cantor Fitzgerald Europe (Nominated Adviser and Broker) --------------------------------------- ---------------- Marc Milmo, David Foreman, Michael Reynolds (Corporate Finance) +44 20 7894 Mark Westcott, David Banks (Sales) 7000 --------------------------------------- ---------------- Luther Pendragon (Financial PR) --------------------------------------- ---------------- Harry Chathli, Claire Norbury, Alexis +44 20 7618 Gore 9100 --------------------------------------- ----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCZMMGZGMKGVZZ
(END) Dow Jones Newswires
December 02, 2016 02:01 ET (07:01 GMT)
1 Year Directa Plus Chart |
1 Month Directa Plus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions